Susquehanna International Group’s Apollo Endosurgery, Inc. APEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-117,400
Closed -$1.16M 13747
2023
Q1
$1.16M Buy
117,400
+28,100
+31% +$278K ﹤0.01% 6419
2022
Q4
$890K Buy
89,300
+54,400
+156% +$406K ﹤0.01% 6436
2022
Q3
$192K Sell
34,900
-7,500
-18% -$41.6K ﹤0.01% 10906
2022
Q2
$155K Buy
42,400
+4,700
+12% +$22.2K ﹤0.01% 10990
2022
Q1
$228K Sell
37,700
-13,200
-26% -$80.4K ﹤0.01% 10934
2021
Q4
$429K Buy
50,900
+32,200
+172% +$281K ﹤0.01% 9579
2021
Q3
$169K Sell
18,700
-7,400
-28% -$63.6K ﹤0.01% 11678
2021
Q2
$211K Sell
26,100
-11,300
-30% -$77.5K ﹤0.01% 11497
2021
Q1
$206K Buy
+37,400
New +$185K ﹤0.01% 11377
2015
Q3
Sell
-796
Closed -$17K 10370
2015
Q2
$17K Buy
796
+597
+300% +$59.1K ﹤0.01% 10013
2015
Q1
$38K Buy
+199
New +$45.7K ﹤0.01% 9198

Susquehanna International Group's APEN Position: Q2 2023 in Review

Susquehanna International Group sold out of Apollo Endosurgery, Inc. (APEN) in Q2 2023, closing a stake of 420,511 shares — an estimated $4.17M sold.

Susquehanna International Group first reported a position in APEN in Q1 2014 and held it in 11 quarters. The position peaked at $4.17M in Q1 2023. 0 funds tracked by Wall St. Rank hold APEN as of Q2 2023.

  • Susquehanna International Group reported no remaining Apollo Endosurgery, Inc. position as of Q2 2023 after selling out during the quarter.
  • Susquehanna International Group sold 420,511 Apollo Endosurgery, Inc. shares in Q2 2023, an estimated $4.17M.
  • Susquehanna International Group first reported a position in Apollo Endosurgery, Inc. in Q1 2014 and held it in 11 quarters.
  • Susquehanna International Group's Apollo Endosurgery, Inc. position peaked at $4.17M in Q1 2023.
  • 0 funds tracked by Wall St. Rank held Apollo Endosurgery, Inc. as of Q2 2023.

Based on Susquehanna International Group's 13F filing for Q2 2023, filed 11 Aug 2023.